Wulff, Hansen & Co’s Merck MRK Stock Holding History

Wulff, Hansen & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Sell	16,940 -585	-3%	-$68.5K	1.67%	16
2026 Q1	$2.11M	Hold	17,525	–	–	2.15%	11
2025 Q4	$1.84M	Sell	17,525 -195	-1%	-$18.3K	1.55%	16
2025 Q3	$1.49M	Sell	17,720 -450	-2%	-$37.1K	1.28%	23
2025 Q2	$1.44M	Sell	18,170 -230	-1%	-$18.3K	1.23%	24
2025 Q1	$1.65M	Hold	18,400	–	–	1.51%	19
2024 Q4	$1.83M	Sell	18,400 -120	-0.6%	-$12.4K	1.73%	17
2024 Q3	$2.1M	Sell	18,520 -1,627	-8%	-$193K	1.91%	13
2024 Q2	$2.49M	Sell	20,147 -706	-3%	-$90.9K	2.46%	8
2024 Q1	$2.75M	Hold	20,853	–	–	2.75%	8
2023 Q4	$2.27M	Sell	20,853 -330	-2%	-$34.3K	2.52%	9
2023 Q3	$2.18M	Buy	21,183 +355	+2%	+$38.3K	2.55%	8
2023 Q2	$2.4M	Hold	20,828	–	–	2.69%	9
2023 Q1	$2.22M	Sell	20,828 -355	-2%	-$38.3K	2.53%	10
2022 Q4	$2.35M	Hold	21,183	–	–	2.85%	7
2022 Q3	$1.82M	Sell	21,183 -10	-0%	-$893	2.28%	14
2022 Q2	$1.93M	Hold	21,193	–	–	2.19%	10
2022 Q1	$1.74M	Buy	21,193 +1,708	+9%	+$135K	1.66%	22
2021 Q4	$1.49M	Buy	+19,485	New	+$1.55M	1.29%	27

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wulff, Hansen & Co's MRK Position: Q2 2026 in Review

Wulff, Hansen & Co reduced its Merck (MRK) stake by 3.3% in Q2 2026, selling an estimated $68.5K and leaving 16,940 shares worth $2.18M. The position accounts for 1.67% of the portfolio, ranked #16.

Wulff, Hansen & Co first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.75M in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Wulff, Hansen & Co held 16,940 shares of Merck worth $2.18M as of Q2 2026.
Wulff, Hansen & Co sold 585 Merck shares in Q2 2026, an estimated $68.5K.
Merck made up 1.67% of Wulff, Hansen & Co's portfolio in Q2 2026, its #16 holding.
Wulff, Hansen & Co first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
Wulff, Hansen & Co's Merck position peaked at $2.75M in Q1 2024.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wulff, Hansen & Co's 13F filing for Q2 2026, filed 5 Aug 2026.